In Reply "As Few as Three Months of Preoperative Semaglutide Exposure Prior to Total Knee Arthroplasty Is Associated With Reduced Postoperative Adverse Events in Patients Who Have Type II Diabetes".

Anthony E Seddio, Jonathan N Grauer, Lee E Rubin